Shares of Ipca Laboratories declined by 2.21% to Rs 1,387.20 in Friday's trading session, as of 10:27 am. The stock is a constituent of the Nifty Midcap 150 index.
Regarding the company's financial performance, the consolidated revenue for the quarter-ending June 2025 stood at Rs 2,308.85 Crore, which is an increase compared to previous quarters. Net profit for the same period was Rs 234.42 Crore, with an Earnings Per Share (EPS) of Rs 9.19.
The consolidated annual revenue for the year-ending March 2025 reached Rs 8,939.59 Crore, and the net profit was Rs 787.53 Crore. The EPS for the year stood at Rs 35.14. Key financial ratios include a debt-to-equity ratio of 0.19 and a P/E ratio of 42.74.
Financial Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS (Rs) |
---|---|---|---|
2021 | 5,419.99 | 1,148.84 | 45.01 |
2022 | 5,829.79 | 910.95 | 34.85 |
2023 | 6,244.32 | 491.93 | 18.58 |
2024 | 7,705.04 | 529.21 | 25.82 |
2025 | 8,939.59 | 787.53 | 35.14 |
Quarter | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS (Rs) |
---|---|---|---|
Jun 2024 | 2,092.63 | 198.98 | 7.58 |
Sep 2024 | 2,354.90 | 245.44 | 9.05 |
Dec 2024 | 2,245.37 | 277.33 | 9.78 |
Mar 2025 | 2,246.69 | 65.78 | 2.67 |
Jun 2025 | 2,308.85 | 234.42 | 9.19 |
Ipca Laboratories announced a final dividend of Rs 2 per share on May 29, 2025, with an effective date of August 5, 2025. Additionally, the company had a stock split on January 10, 2022, where the face value changed from Rs 2 to Rs 1.
Moneycontrol analysis on August 22, 2025, indicated a neutral sentiment for the stock.
With the stock's last traded price at Rs 1,387.20, Ipca Laboratories is currently trading lower compared to its previous closing.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.